Manzo Pharmaceuticals, Inc. Stock Price

OTCPK:MNZO Community·US$110.0k Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

MNZO Share Price Performance

US$0.0001

0.00 (9,900.00%)

US$0.0001

0.00 (9,900.00%)

US$0.0001

Sun, 9 Nov 25

Share PriceUS$0.0001

MNZO Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks

0 Rewards

View Full Analysis

Manzo Pharmaceuticals, Inc. Key Details

Last Reported Earnings

Sep 30, 2005

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About MNZO

Founded: 1980
Employees: n/a
CEO: Kenneth Manzo
WebsiteView website: www.lactofreedom.com

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.